Literature DB >> 6787227

Psychological aspects of artificial feeding in cancer patients.

J R Peteet, C Medeiros, L Slavin, K Walsh-Burke.   

Abstract

Anorexia and weight loss are major physical and psychological problems for patients with cancer, and nutritional support has become an increasingly important part of cancer treatment. Reports discussing the psychological aspects of parenteral feeding have emphasized the importance of the nature of the underlying illness, but special problems surrounding the use of artificial feeding in patients with cancer have not been described. Patterns of emotional response to artificial feeding in such patients are most directly influenced by two interacting sets of variables: the diagnosis and prognosis of cancer, and personality characteristics of patients and family members involved. Typically, management problems result when demoralized patients respond to artificial feeding by becoming more passive, when independent patients struggle over artificial feeding in order to maintain a sense of control, or when anxious patients or families express fears about dying in the form of extreme preoccupation with eating and maintaining weight. An understanding of these patterns has specific implications for improving the patient's cooperation and quality of life.

Entities:  

Mesh:

Year:  1981        PMID: 6787227     DOI: 10.1177/0148607181005002138

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  2 in total

1.  Survey of Psychosocial Issues of Nasogastric Tube Feeding in Head-and-Neck Cancer Patients.

Authors:  Ravi Umrania; Dwija Patel; Bhavna C Patel; Manisha Singh; Priti Sanghavi; Himanshu Patel
Journal:  Indian J Palliat Care       Date:  2021-02-17

2.  Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer.

Authors:  C Roberge; M Tran; C Massoud; B Poirée; N Duval; E Damecour; D Frout; D Malvy; F Joly; P Lebailly; M Henry-Amar
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.